Goldman adds IMCD to its list as IMCD stock sits 35.73 percent below EUR 133

Published on 10/07/2026 at 09:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Goldman sees 40 percent total return for IMCD. IMCD stock costs EUR 97.99 on October 7, 2026 versus EUR 97.68, plus 0.32 percent.

Isometrische 3D-Illustration einer Lieferkette mit Lagerhallen, Schiffen, Lastwagen und Chemieanlagen — Isometrische 3D-Grafik der Wertschöpfungskette illustriert Logistikprozess von IMCD N.V., ISIN NL0010801007, schematisch dargestellt, Illustration mit AI erstellt.

IMCD (ISIN NL0010801007) was trading at EUR 97.99 at Lang & Schwarz on October 7, 2026 at 9:14 a.m. CEST, plus 0.32 percent versus the prior close of EUR 97.68. The latest catalyst is Goldman Sachs adding IMCD to its October European Conviction List on October 2, 2026, alongside a EUR 133 12-month price target and projected total return of 40 percent, as CNBC reported.

Goldman highlights margin potential

Goldman analyst Suhasini Varanasi pointed to IMCD's specialized, higher-value chemical ingredients and its ability to pass on oil-price inflation and supply-chain volatility. The analysis says these factors could support profitability and make margins more resilient than those of commodity chemical distributors, while improving economic data could support volumes, according to Investing.com on October 1, 2026.

The EUR 133 target stands 35.73 percent above the Lang & Schwarz price of EUR 97.99. That comparison gives the Goldman call a measurable valuation reference, but it does not remove execution risks tied to regional demand, acquisitions and the conversion of volume recovery into operating profit.

First-half earnings support the case

IMCD reported revenue of EUR 2.65 billion for the first half of 2026, up 6.6 percent from the first half of 2025. Net income rose 9.7 percent to EUR 142.3 million, while earnings per share increased to EUR 2.41 from EUR 2.20, according to Simply Wall St.

Operating EBITA for the first half rose 4 percent to EUR 285 million, while free cash flow and acquisitions remained important parts of the investment story. The combination of organic growth, specialized products and acquisition-led expansion explains why analysts are emphasizing margin recovery rather than revenue alone.

Next results arrive in November

IMCD's next scheduled financial milestone is publication of its first nine months 2026 results on November 5, 2026, according to the company's investor-relations calendar at IMCD. That release should provide the next dated test of volume recovery, margin development and progress toward lower leverage.

IMCD was trading at EUR 97.99 at Lang & Schwarz on October 7, 2026 at 9:14 a.m. CEST, plus 0.32 percent versus the prior close of EUR 97.68. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.